Cystatin C in acute kidney injury diagnosis: early biomarker or alternative to serum creatinine?

BACKGROUND: Early accurate acute kidney injury (AKI) diagnosis is needed to pursue AKI treatment trials. We evaluated Cystatin C (CysC) as an early biomarker of serum creatinine (SCr)-AKI and as an alternative to define AKI. METHODS: 160 non-cardiac children admitted to our intensive care unit (ICU)...

Description complète

Enregistré dans:
Détails bibliographiques
Publié dans:Pediatr Nephrol
Auteurs principaux: Lagos-ArevaloBSc, Paola, Palijan, Ana, VertulloBSc, Laura, Devarajan, Prasad, Bennett, Michael R., Sabbisetti, Venkata, Bonventre, Joseph V., Ma, Qing, Gottesman, Ronald D., Zappitelli, Michael
Format: Artigo
Langue:Inglês
Publié: 2014
Sujets:
Article
Accès en ligne:https://ncbi.nlm.nih.gov/pmc/articles/PMC4372053/
https://ncbi.nlm.nih.gov/pubmed/25475610
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s00467-014-2987-0
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!

Documents similaires